Methods of Immunoprophylaxis Against Bovine Anaplasmosis with Emphasis on use of the Attenuated Anaplasma Marginale Vaccine

  • Miodrag Ristic
  • C. A. Carson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 93)


One of the major obstacles to the development of methods for immunoprophy-laxis against hemotropic diseases has been the lack of techniques for in vitro propagation of the causative agents (Anaplasma, Babesia), or the availability of similar systems for laboratory production of arthropod-associated “prototype” antigens (trypanosomes). A recent accomplishment in this direction has been the development of cell culture methods for Theileria parva, the causative agent of East Coast fever. While this step is considered an important breakthrough providing incentive for more optimistic future endeavors in the entire field, the accomplishment must not be viewed as an indication that this technique can be directly applied to other hemotropic agents. Theileria parva actively invades cellular elements of both the erythrocytic and lymphocytic series, the latter being adapted to in vitro propagation. Anaplasma, Babesia, and Plasmodium are considered to primarily affect the more inert circulating erythrocyte which, rather than offering replication ability in cell culture, continues its in vivo destiny of degeneration.


Stimulation Index Infected Erythrocyte Blood Parasite Bovine Erythrocyte Lymphocyte Transformation Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amerault, T.E. & Roby, T.O. 1964. An exo-antigen of A. marginale in serum and erythrocytes of cattle with acute anaplasmosis. Am. J. Vet. Res. 25: 1642–1647.PubMedGoogle Scholar
  2. Amerault, T.E. & Roby, T.O. 1967. Preparation and characterization of a solu-able Anaplasma marginale antigen. Am. J. Vet. Res. 28: 1067–1072.PubMedGoogle Scholar
  3. Amerault, T.E. & Roby, T.O. 1968. A rapid card agglutination test for bovine anaplasmosis. J. Am. Vet. Med. Assoc. 153: 1828–1834.Google Scholar
  4. Amerault, T.E., Roby, T.O. & Sealock, R.L. 1975. Ultrastructure oî Anaplasma marginale after freeze-fracture. Am. J. Vet. Res. 36: 1515–1519.PubMedGoogle Scholar
  5. Brock, W.E., Kliewer, I.O. & Pearson, C.C. 1965. A vaccine for anaplasmosis. J. Am. Vet. Med. Assoc. 147: 948–951.Google Scholar
  6. Buening, G.M. 1973. Cell-mediated immune responses in calves with anaplasmosis. Am. J. Vet. Res. 34: 757–763.PubMedGoogle Scholar
  7. Carson, C.A. 1975. Measurement of cell-mediated immune response in cattle induced by virulent and attenuated strains of Anaplasma marginale introduced in both live and killed form and correlation with protective immunity. Ph.D. thesis, University of Illinois at Champaign-Urbana.Google Scholar
  8. Carson, C.A., Adams, L.G. & Todorovic, R.A. 1970. An antigenic and serologic comparison of two virulent strains and an attenuated strain of Anaplasma marginale. Am. J. Vet. Res. 31: 1071–1078.Google Scholar
  9. Carson, C.A., Weisiger, R.M., Ristic, M., Thurmon, J.C. & Nelson, D.R. 1974. Appendage-related antigen production by Paranaplasma caudatum in deer erythrocytes. Am. J. Vet. Res. 35: 1529–1531.PubMedGoogle Scholar
  10. Castillo, A.G. 1968. Laboratory and field trails of attenuated Anaplasma marginale vaccine in Peru. In Proceedings of the 5th National Anaplasmosis Conference: 88–96. Stillwater, Okla.Google Scholar
  11. Dennis, R.A., O’Hara, P.J., Young, M.F. & Dorris, K.D. 1970. Neonatal im-munohemolytic anemia and icterus of calves. J. Am. Vet. Med. Assoc. 156: 1861–1869.PubMedGoogle Scholar
  12. Erp, E. & Fahrney, D. 1975. Exit of Anaplasma marginale from bovine red blood cells. Am. J. Vet. Res. 36: 707–709.Google Scholar
  13. Franklin, T.E., Heck, F.C. & Huff, J.W. 1963. Anaplasmosis-complement-fixation antigen production. Am. J. Vet. Res. 24: 483–487.PubMedGoogle Scholar
  14. Franklin, T.E. & Huff, J.W. 1967. A proposed method of premunizing cattle with minimum inocula oí Anaplasma marginale. Res. Vet. Sci. 8: 415–418.Google Scholar
  15. Gewurz, H. 1975. School of Medicine, Presbyterian-St. Luke’s Hospital, Chicago, Illinois. Personal communication.Google Scholar
  16. Greenwood, B.M. 1974. Possible role of a B-cell mitogen in hypergammaglobulinemia in malaria and trypanosomiasis. Lancet 1: 435–436.PubMedCrossRefGoogle Scholar
  17. Hines, H.C., Bedell, D.M., Kliewer, I.O. & Hayat, C.S. 1973. Some effects of blood antigens on A. marginale and other vaccines. In Proceedings of the 6th National Anaplasmosis Conference: 82–85. Las Vegas, Nevada.Google Scholar
  18. Holbrook, A.A., Anthony, D.W. & Johnson, A.J. 1968. Observations on the development of Babesia caballi (Nuttall) in the tropical horse tick Dermacentor nitens Neumann. J. Protozool. 15: 391–396.Google Scholar
  19. Jones, T.C. 1974. Macrophages and intracellular parasitism. J. Reticuloendothel Soc. 15:439–450.PubMedGoogle Scholar
  20. Kliewer, I.O., Richey, E.L., Jones, E.W. & Brock, W.E. 1973. The preservation and minimum infective dose of A. marginale. In Proceedings of the 6th National Anaplasmosis Conference: 39–41. Las Vegas, Nevada.Google Scholar
  21. Kreier, J.P. & Ristic, M. 1963a. Anaplasmosis. X. Morphologic characteristics of the parasite present in the blood of calves infected with the Oregon strain of Anaplasma marginale. Am. J. Vet. Res. 24: 676–687.Google Scholar
  22. Kreier, J.P. & Ristic, M. 1963b. Anaplasmosis. XI. Immunoserologic characteristics of the parasites present in the blood of calves infected with the Oregon strain of Anaplasma marginale. Am. J. Vet. Res. 24: 688–696.Google Scholar
  23. Kreier, J.P. & Ristic, M. 1963c. Anaplasmosis. XII. The growth and survival in deer and sheep of the parasites present in the blood of calves infected with the Oregon strain of Anaplasma marginale. Am. J. Vet. Res. 24: 697–702.Google Scholar
  24. Kreier, J.P. & Ristic, M. 1972. Definition and taxonomy of Anaplasma species with emphasis on morphologic and immunologic features. Z. Tropenmed. Parasitol. 23:88–98.PubMedGoogle Scholar
  25. Kuttler, K.L. 1966. Clinical and hematologic comparison of Anaplasma marginale and Anaplasma centrale infections in cattle. Am. J. Vet. Res. 27: 941–946.PubMedGoogle Scholar
  26. Kuttler, K.L. 1967a. Serological relationship of Anaplasma marginale and Ana-plasma centrale as measured by the complement-fixation and capillary tube agglutination tests. Res. Vet. Sci. 8: 207–211.PubMedGoogle Scholar
  27. Kuttler, K.L. 1967b. A study of the immunological relationship of Anaplasma marginale and Anaplasma centrale. Res. Vet. Sci. 8: 467–471.Google Scholar
  28. Kuttler, K.L. 1972. Comparative response to premunization using attenuated Anaplasma marginale, virulent A. marginale, and A. centrale in different age groups. Trop. Anim. Health Prod. 4: 197–203.PubMedCrossRefGoogle Scholar
  29. Legg, J. 1936. Anaplasmosis cross-immunity tests between Anaplasma centrale (South Africa) and Anaplasma marginale (Australia). Aust. Vet. J. 12: 230–233.CrossRefGoogle Scholar
  30. Lora, C.O. 1971. Enfermedades por hematozoarios del ganado bovino del Peru: Rev. Inst. Zoonosis Invest. Pecu., Lima 1: 15–19.Google Scholar
  31. Lora, C.O. & Koechlin, A. 1969. An attenuated Anaplasma marginale vaccine in Peru. Am. J. Vet. Res. 30: 1993–1998.PubMedGoogle Scholar
  32. Mason, R.A. & Ristic, M. 1966. In vitro incorporation of glycine by bovine erythrocytes infected with Anaplasma marginale. J. Infect. Dis. 116: 335–342.PubMedCrossRefGoogle Scholar
  33. McCallon, B.R. 1973. Prevalence and economic aspects of anaplasmosis. In Proceedings of the 6th National Anaplasmosis Conference: 1–3. Las Vegas, Nevada.Google Scholar
  34. McHardy, N. & Simpson, R.M. 1973. Attempts at immunizing cattle against anaplasmosis using a killed vaccine. Trop. Anim. Health Prod. 5: 166–173.PubMedCrossRefGoogle Scholar
  35. Moulder, J.W. 1974. Intracellular parasitism: life in an extreme environment. J. Infect. Dis. 130: 300–306.PubMedCrossRefGoogle Scholar
  36. Murphy, F.A., Aalund, O. & Osebold, J.W. 1964. Physical heterogeneity of bovine gamma globulins: Gamma-1M globulin electrophoretic heterogeneity. Proc. Soc. of Exp. Biol Med. 117: 513–517.Google Scholar
  37. Murphy, F.A., Osebold, J.W., & Aalund, O. 1966. Kinetics of the antibody response to Anaplasma marginale infection. J. Infect. Dis. 116: 99–111.PubMedCrossRefGoogle Scholar
  38. Osorno, B.M. 1975. Unpublished data: Instituto Nacional de Investigaciones Pecuarias, Mexico, D.F., Mexico.Google Scholar
  39. Osorno, B.M., Solana, P.M., Perez, J.M. & Trujillo, R.L. 1975. Study of an attenuated Anaplasma marginale vaccine in Mexico — natural challenge of immunity in an enzootic area. Am. J. Vet. Res. 36: 631–633.PubMedGoogle Scholar
  40. Osorno, B.M., Solana, P. & Ristic, M. 1973. Study of an attenuated A. marginale vaccine in Mexico: I. Challenge of immunity by a virulent endemic anaplasma strain. In Proceedings of the 6th National Anaplasmosis Conference: 113–116. Las Vegas, Nevada.Google Scholar
  41. Popovic, N.A. 1968. Pathogenesis of two strains of Anaplasma marginale in Derma-centor andersoni tick. Ph.D. thesis, University of Illinois, Urbana, Illinois.Google Scholar
  42. Porter, R. & Knight, J. eds. 1974. Parasites in the Immunized Host: 1–280. Mechanisms of Survival. Ciba Foundation Symposium 25 (new series). Associated Scientific Publishers. Amsterdam, The Netherlands.Google Scholar
  43. Price, W.H. 1954. Variation in virulence of “Rickettsia rickettsii” under natural and experimental conditions. In The Dynamics of Virus and Rickettsial Infection, Hartman, F.W., Horsfall, F.L., Jr. & Kidd, J.G., Eds.: 164–183. Blakiston, New York.Google Scholar
  44. Rao, P.J. & Ristic, M. 1963. Serum sialic acid levels in experimental anaplasmosis. Proc. Soc. Exp. Biol. Med. 114: 447–452.PubMedGoogle Scholar
  45. Ristic, M. 1960. Anaplasmosis. Adv. Vet. Sci. 6: 111–192.Google Scholar
  46. Ristic, M. 1962. A capillary tube-agglutination test for anaplasmosis — a preliminary report. J. Am. Vet. Med. Assoc. 141: 588–594.PubMedGoogle Scholar
  47. Ristic, M. 1968. Anaplasmosis. In Infectious Blood Diseases of Man and Animals, Weinman D. & Ristic, M., Eds. 2: 478–542. Academic Press, Inc. New York, New York.Google Scholar
  48. Ristic, M. & Kreier, J.P. 1974. Family Anaplasmataceae. In Bergey’s Manual of Determinative Bacteriology, Buchanan, R.E. & Gibbons, N.E., Eds. 8: 906–908. William & Wilkins. Baltimore, Maryland.Google Scholar
  49. Ristic, M., Lykins, J.D. & Morris, H.R. 1972. Anaplasmosis: opsonins and hemagglutinins in etiology of anemia. Exp. Parasitol. 31:2–12.PubMedCrossRefGoogle Scholar
  50. Ristic, M. & Mann, D.K. 1963, Anaplasmosis IX. Immunologic properties of soluable anaplasma antigen. Am. J. Vet. Res. 24: 478–482.PubMedGoogle Scholar
  51. Ristic, M., Mann, D.K. & Kodras, R. 1963. Anaplasmosis VIII. Biochemical and biophysical characterization of soluble anaplasma antigens. Am. J. Vet. Res. 24: 472–477.PubMedGoogle Scholar
  52. Ristic, M. & Nyindo, M.B.A. 1973. Mechanisms of immune response to an attenuated Anaplasma marginale vaccine. In Proceedings of the 6th National Anaplasmosis Conference: 66–70. Las Vegas, Nevada.Google Scholar
  53. Ristic, M., Sibinovic, S. & Welter, C.J. 1968. An attenuated Anaplasma marginale vaccine. Proc. U.S. Livestock Sanit. Assoc. 72: 56–69.Google Scholar
  54. Ristic, M. & Watrach, A.M. 1961. Studies in anaplasmosis: II Electron microscopy of Anaplasma marginale in deer. Am. J. Vet. Res. 22: 109–116.PubMedGoogle Scholar
  55. Ristic, M. & Watrach, A.M. 1963. Anaplasmosis. VI. Studies and a hypothesis concerning the cycle of development of the causative agent. Am. J. Vet. Res. 24: 267–277.PubMedGoogle Scholar
  56. Roby, T.O., Amerault, T.E., Mazzola, V., Rose, J.E. & Ilamobade, A. 1974. Immunity in bovine anaplasmosis after elimination of Anaplasma marginale infections withimidocarb. Am. J. Vet. Res. 35: 993–995.Google Scholar
  57. Schindler, R., Ristic, M. & Wokatsch, R. 1966. Vergleichende Untersuchungen mit Anaplasma marginale und A. Centrale. Z. Tropenmed. Parasitol. 17: 337–360.Google Scholar
  58. Schmidt, H.E. 1937. Anaplasmosis in cattle. J. Am. Vet. Med. Assoc. 90: 723–736.Google Scholar
  59. Schroeder, W.F., Rivas, C.E.L., Benitez, M.T. & Lopez, B.R. 1971. Anaplasmosis prevencion y control. Ministerio de Agricultura y Cria, Centro de Investigaciones Veterinarias: 129. Maracay, Venezuela.Google Scholar
  60. Simpson, C.F., Kling, J.M., Love, J.N. 1967. Morphologic and histochemical nature of Anaplasma marginale. Am. J. Vet. Res. 28: 1055–1065.Google Scholar
  61. Taylor, Robert L. 1969. Immunogenic differences between two Anaplasma marginale isolates. Am. J. Vet. Res. 30: 1999–2002.PubMedGoogle Scholar
  62. Theiler, A. 1910. Anaplasma marginale. The marginal points in the blood of cattle suffering from specific disease. In Report of the Veterinary Bacteriologist, Dept. of Agriculture, Union of South Africa, Pretoria, 1908–1909: 6–64.Google Scholar
  63. Vizcaino, O.G., Carson, C.A., Lee, A.J. & Ristic, M. 1976. Response of calves to various doses of attenuated Anaplasma marginale vaccine and effect of challenge. (In preparation)Google Scholar
  64. Welter, C.J. & Ristic, M. 1969. Laboratory and Field Trials with an attenuated Anaplasma marginale vaccine. Proc. U.S. Anim. Health Assoc. 73: 122–130.Google Scholar
  65. Welter, C.J. & Woods, R.D. 1963. Preliminary evaluation of an attenuated Anaplasma marginale vaccine in cattle. Vet. Med. Small Anim. Gin. 63: 798–802.Google Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Miodrag Ristic
    • 1
  • C. A. Carson
    • 1
  1. 1.Department of Veterinary Pathology and Hygiene College of Veterinary MedicineUniversity of Illinois at Champaign-UrbanaUrbanaUSA

Personalised recommendations